d-alpha tocopherol has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abletshauser, C; Hanefeld, M; Jaross, W; Kurktschiev, T; Lattke, P; Leonhardt, W; Meissner, D; Weidinger, G | 1 |
| Suzuki, T; Suzumura, K; Tanaka, K; Yasuhara, M | 1 |
| Narita, H; Odawara, A; Suzuki, T; Suzumura, K; Tanaka, K; Yasuhara, M | 1 |
| Narita, H; Suzumura, K; Yasuhara, M | 1 |
| Narita, H; Suzumura, K; Tanaka, K; Yasuhara, M | 1 |
| Kersting, F; Selenka, A; Walch, S | 1 |
| Aoki, S; Ikeda, K; Kojo, S; Yamamura, M | 1 |
| Itakura, H | 1 |
| Iwasaki, K; Kuroda, N; Nakashima, A; Nakashima, K; Ohtawa, M; Wada, M | 1 |
| Narita, H; Ohashi, N; Oka, K; Suzumura, K; Yasuhara, M | 1 |
| Haginaka, J; Kagota, S; Kunitomo, M; Matsuno, S; Yamaguchi, Y | 1 |
| Ashida, T; Katoh, M; Kurabayashi, M; Kurihara, H; Morita, H; Nagai, R; Nakamura, T; Ohashi, N; Saito, Y; Yoshikawa, M | 1 |
| Oka, K; Sawamura, T; Suzumura, K; Tanaka, K; Yasuhara, M | 1 |
1 review(s) available for d-alpha tocopherol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
[Antioxidants].
Topics: Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotenoids; Clinical Trials as Topic; Coronary Disease; Fatty Acids, Monounsaturated; Flavonoids; Fluvastatin; Humans; Indoles; Oxidative Stress; Phenols; Polymers; Polyphenols; Probucol; Vitamin E | 2001 |
2 trial(s) available for d-alpha tocopherol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals.
Topics: Anticholesteremic Agents; Antioxidants; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Lipid Metabolism; Lipids; Lipoproteins, LDL; Male; Metals; Middle Aged; Vitamin A; Vitamin E | 1997 |
Effects of cholestyramine on vitamin E levels in patients treated with statins.
Topics: Adult; Aged; Anticholesteremic Agents; Antioxidants; Cholesterol, LDL; Cholestyramine Resin; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Lovastatin; Male; Middle Aged; Naphthalenes; Pravastatin; Simvastatin; Vitamin E | 2000 |
10 other study(ies) available for d-alpha tocopherol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro.
Topics: Adult; Amidines; Antioxidants; Copper; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins, LDL; Male; Oxidants; Oxidation-Reduction; Structure-Activity Relationship; Vitamin E | 1999 |
An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor.
Topics: Biotransformation; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Humans; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Thiourea; Vitamin E | 1999 |
Superoxide anion scavenging properties of fluvastatin and its metabolites.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Methylphenazonium Methosulfate; NAD; Neutrophils; Nitroblue Tetrazolium; Superoxides; Vitamin E | 1999 |
Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein.
Topics: Analysis of Variance; Antioxidants; Ascorbic Acid; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Hemin; Humans; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Iron Chelating Agents; Lipoproteins, LDL; Male; Oxidation-Reduction; Vitamin E | 2000 |
Protective effect of fluvastatin on degradation of apolipoprotein B by a radical reaction in human plasma.
Topics: Anticholesteremic Agents; Apolipoproteins B; Copper; Fatty Acids, Monounsaturated; Fluvastatin; Free Radicals; Humans; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Vitamin E | 2001 |
Inhibitory effects of fluvastain and its metabolites on the formation of several reactive oxygen species.
Topics: Animals; Antioxidants; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Microsomes, Liver; Oxygen; Pravastatin; Probucol; Rats; Reactive Oxygen Species; Simvastatin; Singlet Oxygen; Vitamin E | 2001 |
Fluvastatin depresses the enhanced lipid peroxidation in vitamin E-deficient hamsters.
Topics: Animals; Body Weight; Chromatography, High Pressure Liquid; Cricetinae; Dinoprost; Eating; F2-Isoprostanes; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Lipid Peroxidation; Lipid Peroxides; Liver; Myocardium; Oxidation-Reduction; Oxidative Stress; Time Factors; Vitamin E; Vitamin E Deficiency | 2001 |
Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin.
Topics: Animals; Antioxidants; Apolipoproteins; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; In Vitro Techniques; Indoles; Lipoproteins, LDL; Male; Oxidation-Reduction; Oxidative Stress; Peroxynitrous Acid; Rabbits; Smoking; Tyrosine; Vitamin E | 2004 |
Fluvastatin ameliorates the hyperhomocysteinemia-induced endothelial dysfunction: the antioxidative properties of fluvastatin.
Topics: Animals; Antioxidants; Disease Models, Animal; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fluvastatin; Hyperhomocysteinemia; Hyperlipidemias; Indoles; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vasodilation; Vitamin E | 2005 |
Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits.
Topics: Animals; Antioxidants; Atherosclerosis; Cholesterol; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Ligands; Lipoproteins, LDL; Male; Rabbits; Scavenger Receptors, Class E; Vitamin E | 2006 |